UPDATED Aug 31, 2025
Discover small cap Global Pharmaceuticals & Biotech companies from around the world. These Pharmaceuticals & Biotech Companies are organised by Market Cap.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
1795 | NT$188.00 | -2.8% | -34.4% | NT$49.4b | NT$322.40 | PE10.2x | E0.8% | 3.0% | ||
IMCR | US$32.22 | -1.1% | -10.2% | US$1.6b | US$62.20 | PS4.6x | E53.7% | n/a | ||
TWST | US$26.97 | -1.5% | -37.6% | US$1.6b | US$40.00 | PS4.5x | E47.5% | n/a | ||
BHVN | US$15.39 | 3.0% | -60.9% | US$1.6b | US$47.14 | PB12.1x | E16.9% | n/a | ||
601089 | CN¥24.87 | -6.2% | 67.2% | CN¥11.6b | n/a | PE25x | n/a | 2.0% | ||
SQURPHARMA | ৳225.00 | 0.8% | -2.3% | ৳199.5b | ৳325.67 | PE8.5x | E11.3% | 4.9% | ||
CDTX | US$65.39 | 2.0% | 450.0% | US$1.7b | US$79.80 | PB3.3x | E0.6% | n/a | ||
2171 | HK$23.44 | 6.1% | 668.5% | HK$13.0b | HK$22.64 | PS141.3x | E118.2% | n/a | ||
600993 | CN¥27.65 | -2.6% | 17.0% | CN¥11.9b | CN¥35.75 | PE22.3x | E18.0% | 2.2% | ||
PHM | €81.30 | -0.3% | 95.2% | €1.4b | €104.60 | PE34x | E44.2% | 1.0% | ||
688513 | CN¥69.16 | -2.1% | 91.0% | CN¥12.0b | CN¥43.00 | PE52.4x | E18.1% | 0.6% | ||
TRUL | CA$12.07 | 1.4% | 3.0% | CA$2.3b | CA$17.89 | PS1.4x | E85.6% | n/a | ||
300026 | CN¥4.00 | -6.5% | 25.0% | CN¥12.0b | CN¥4.30 | PS2.2x | E53.4% | 0.7% | ||
600645 | CN¥26.42 | -6.5% | 46.5% | CN¥12.0b | n/a | PE136.5x | n/a | n/a | ||
COGT | US$12.08 | 2.5% | 12.5% | US$1.7b | US$20.36 | PB35.8x | E51.9% | n/a | ||
MSB | AU$2.02 | -17.6% | 90.6% | AU$2.6b | AU$3.49 | PS98.5x | E56.1% | n/a | ||
9887 | HK$66.80 | -1.8% | n/a | HK$13.3b | n/a | PB63.1x | n/a | n/a | ||
688319 | CN¥29.97 | -8.3% | 242.1% | CN¥12.2b | CN¥27.55 | PE306.6x | E16.5% | 0% | ||
SKAN | CHF 61.40 | -7.3% | -24.1% | CHF 1.4b | CHF 84.00 | PE85.3x | E28.6% | 0.7% | ||
GXI | €43.12 | -5.8% | -58.4% | €1.5b | €66.84 | PE23.5x | E28.3% | 0.09% | ||
TXG | US$14.01 | -0.4% | -40.0% | US$1.7b | US$15.08 | PS2.7x | E-4.0% | n/a | ||
BCRX | US$8.31 | -1.0% | -4.4% | US$1.7b | US$16.73 | PS3.1x | E48.6% | n/a | ||
NATCOPHARM | ₹864.80 | -1.1% | -43.8% | ₹154.9b | ₹982.64 | PE9.1x | E-41.1% | 0.7% | ||
600129 | CN¥22.72 | -4.2% | 4.6% | CN¥12.7b | CN¥24.00 | PS1.2x | E77.3% | 0% |